tobramycin pen peptide conjugate (University of California Los Angeles)

N/A

Report date: 2025/03/20 10:05:13

Base Information

Drug Nametobramycin pen peptide conjugate (University of California Los Angeles)
Drug Alias Namepen peptidepentobra
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsPropionibacterium acnes infectionStreptococcal InfectionsEscherichia coli Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of California, Los Angeles
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of California, Los Angeles
Inactive CompaniesN/A
Active IndicationsPropionibacterium acnes infectionStreptococcal InfectionsEscherichia coli Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A